Complement inhibition as a therapeutic strategy in retinal disorders
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Complement inhibition as a therapeutic strategy in retinal disorders
Authors
Keywords
-
Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 19, Issue 4, Pages 335-342
Publisher
Informa UK Limited
Online
2019-01-26
DOI
10.1080/14712598.2019.1575358
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration
- (2018) Frank G. Holz et al. JAMA Ophthalmology
- Visual Acuity Change over 12 Months in the Prospective Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study
- (2017) Xiangrong Kong et al. OPHTHALMOLOGY
- Complement modulation in the retinal pigment epithelium rescues photoreceptor degeneration in a mouse model of Stargardt disease
- (2017) Tamara L. Lenis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration
- (2017) Brian L. Yaspan et al. Science Translational Medicine
- Multimodal imaging of retinal pigment epithelial detachments in patients with C3 glomerulopathy: case report and review of the literature
- (2017) Valeria Kheir et al. BMC Ophthalmology
- Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study
- (2017) Etienne M. Schönbach et al. JAMA Ophthalmology
- Incidence of Atrophic Lesions in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study
- (2017) Rupert W. Strauss et al. JAMA Ophthalmology
- Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9)
- (2017) Rupert W. Strauss et al. JAMA Ophthalmology
- The Complement Regulatory Protein CD46 Deficient Mouse Spontaneously Develops Dry-Type Age-Related Macular Degeneration–Like Phenotype
- (2016) Valeriy V. Lyzogubov et al. AMERICAN JOURNAL OF PATHOLOGY
- CFH Y402H polymorphism and the complement activation product C5a: effects on NF-κB activation and inflammasome gene regulation
- (2016) Sijia Cao et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Randomized Trial to Evaluate Tandospirone in Geographic Atrophy Secondary to Age-Related Macular Degeneration: The GATE Study
- (2015) Glenn J. Jaffe et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- The Membrane Attack Complex in Aging Human Choriocapillaris
- (2014) Robert F. Mullins et al. AMERICAN JOURNAL OF PATHOLOGY
- Highly Penetrant Alleles in Age-Related Macular Degeneration
- (2014) A. I. den Hollander et al. Cold Spring Harbor Perspectives in Medicine
- Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
- (2014) Wan Ling Wong et al. Lancet Global Health
- Mechanisms of age-related macular degeneration and therapeutic opportunities
- (2013) Menno van Lookeren Campagne et al. JOURNAL OF PATHOLOGY
- A functional variant in the CFI gene confers a high risk of age-related macular degeneration
- (2013) Johannes P H van de Ven et al. NATURE GENETICS
- Systemic Complement Inhibition with Eculizumab for Geographic Atrophy in Age-Related Macular Degeneration
- (2013) Zohar Yehoshua et al. OPHTHALMOLOGY
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
- (2012) Daniel F. Martin et al. OPHTHALMOLOGY
- Age-related macular degeneration and the complement system
- (2011) S. Khandhadia et al. IMMUNOBIOLOGY
- Complement System Dysregulation and Inflammation in the Retinal Pigment Epithelium of a Mouse Model for Stargardt Macular Degeneration
- (2011) Roxana A. Radu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A rare variant in CFH directly links age-related macular degeneration with rare glomerular nephropathies
- (2011) Alan F. Wright NATURE GENETICS
- A rare penetrant mutation in CFH confers high risk of age-related macular degeneration
- (2011) Soumya Raychaudhuri et al. NATURE GENETICS
- A Non Membrane-Targeted Human Soluble CD59 Attenuates Choroidal Neovascularization in a Model of Age Related Macular Degeneration
- (2011) Siobhan M. Cashman et al. PLoS One
- Cell culture model that mimics drusen formation and triggers complement activation associated with age-related macular degeneration
- (2011) L. V. Johnson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation